Cybin (HELP) Exchange Rate Effect (2020 - 2025)
Cybin (HELP) reported Exchange Rate Effect of -$36239.7 for Q1 2025, down 190.43% on a YoY basis from $40074.1 in Q1 2024, and down 100.53% quarter-over-quarter from $6.9 million in Q4 2024.
Cybin (HELP) Exchange Rate Effect (2020 - 2025) Analysis & Trends
Cybin has reported Exchange Rate Effect for 6 years, with the latest figure at -$36239.7 in Q1 2025.
- For the quarter ending Q1 2025, Exchange Rate Effect fell 190.43% year-over-year to -$36239.7; the trailing twelve-month figure through Mar 2025 stood at $6.5 million (up 5655.61% YoY), and the FY2025 full-year result was $6.5 million, up 5544.44% from the prior year.
- Exchange Rate Effect for Q1 2025 stood at -$36239.7, down from $6.9 million in the prior quarter.
- The five-year high for Exchange Rate Effect was $6.9 million in Q4 2024, with the low at -$1.9 million in Q2 2022.
- Historically, Exchange Rate Effect has averaged $224510.1 across 5 years, with a median of -$842.2 in 2021.
- Annual changes were most pronounced in 2022 — Exchange Rate Effect surged 6012.79% — and 2024, when it plunged 2321.36%.
- Cybin's Exchange Rate Effect stood at -$15073.4 in 2021, then surged by 554.53% to $68513.4 in 2022, then tumbled by 399.12% to -$204935.4 in 2023, then soared by 3445.64% to $6.9 million in 2024, then tumbled by 100.53% to -$36239.7 in 2025.
- The last three Exchange Rate Effect figures came in at -$36239.7 (Q1 2025), $6.9 million (Q4 2024), and -$1.8 million (Q3 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.60 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -2.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -40.30 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 8.68 Mn |
| 10 | Cybin | 75.42 Mn | 75.42 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | -36,239.66 |
| Mar 31, 2025 | -36,239.66 |
| Dec 31, 2024 | 6.86 Mn |
| Dec 31, 2024 | 6.86 Mn |
| Sep 30, 2024 | -1.76 Mn |
| Sep 30, 2024 | -1.76 Mn |
| Jun 30, 2024 | 1.44 Mn |
| Jun 30, 2024 | 1.44 Mn |
| Mar 31, 2024 | 40,074.11 |
| Mar 31, 2024 | 40,074.11 |
| Dec 31, 2023 | -204,935.41 |
| Dec 31, 2023 | -204,935.41 |
| Sep 30, 2023 | 79,068.63 |
| Sep 30, 2023 | 79,068.63 |
| Jun 30, 2023 | -31,267.00 |
| Jun 30, 2023 | -31,267.00 |
| Feb 28, 2023 | -1.43 Mn |
| Feb 28, 2023 | -1.43 Mn |
| Dec 31, 2022 | 68,513.37 |
| Dec 31, 2022 | 68,513.37 |